Parkinson's disease risk and hyperhomocysteinemia: the possible link
HM Al-Kuraishy, AI Al-Gareeb, YHA Elewa… - Cellular and Molecular …, 2023 - Springer
Parkinson's disease (PD) is one of the most common degenerative brain disorders caused
by the loss of dopaminergic neurons in the substantia nigra (SN). Lewy bodies and …
by the loss of dopaminergic neurons in the substantia nigra (SN). Lewy bodies and …
Hyperhomocysteinemia and cardiovascular diseases.
R Guieu, J Ruf, G Mottola - Annales de biologie clinique, 2022 - search.ebscohost.com
Homocysteine (Hcy) is a sulfhydryl-containing amino acid, which is not acquired through the
diet, but rather synthesized as an intermediate metabolite in the methionine cycle. Hcy is …
diet, but rather synthesized as an intermediate metabolite in the methionine cycle. Hcy is …
Prenatal hyperhomocysteinemia induces glial activation and alters neuroinflammatory marker expression in infant rat hippocampus
AD Shcherbitskaia, DS Vasilev, YP Milyutina… - Cells, 2021 - mdpi.com
Maternal hyperhomocysteinemia is one of the common complications of pregnancy that
causes offspring cognitive deficits during postnatal development. In this study, we …
causes offspring cognitive deficits during postnatal development. In this study, we …
Maternal hyperhomocysteinemia disturbs the mechanisms of embryonic brain development and its maturation in early postnatal ontogenesis
DS Vasilev, AD Shcherbitskaia, NL Tumanova… - Cells, 2023 - mdpi.com
Maternal hyperhomocysteinemia causes the disruption of placental blood flow and can lead
to serious disturbances in the formation of the offspring's brain. In the present study, the …
to serious disturbances in the formation of the offspring's brain. In the present study, the …
Increased plasma DYRK1A with aging may protect against neurodegenerative diseases
JM Delabar, J Lagarde, M Fructuoso… - Translational …, 2023 - nature.com
Early markers are needed for more effective prevention of Alzheimer's disease. We
previously showed that individuals with Alzheimer's disease have decreased plasma …
previously showed that individuals with Alzheimer's disease have decreased plasma …
Homocysteine decreases VEGF, EGF, and TrkB levels and increases CCL5/RANTES in the hippocampus: Neuroprotective effects of rivastigmine and ibuprofen
OVR Júnior, JS Silveira, D Gusso… - Chemico-Biological …, 2024 - Elsevier
Homocysteine (Hcy) is produced through methionine transmethylation. Elevated Hcy levels
are termed Hyperhomocysteinemia (HHcy) and represent a risk factor for neurodegenerative …
are termed Hyperhomocysteinemia (HHcy) and represent a risk factor for neurodegenerative …
Neurodegenerative Etiology of Aromatic L-Amino Acid Decarboxylase Deficiency: a Novel Concept for Expanding Treatment Strategies
Z Sternberg - Molecular Neurobiology, 2024 - Springer
Aromatic l-amino acid decarboxylase deficiency (AADC-DY) is caused by one or more
mutations in the DDC gene, resulting in the deficit in catecholamines and serotonin …
mutations in the DDC gene, resulting in the deficit in catecholamines and serotonin …
High-protein nutrition during pregnancy increases neuroinflammation and homocysteine levels and impairs behavior in male adolescent rats offspring
JS Silveira, OVR Júnior, F Schmitz, FS Ferreira… - Life Sciences, 2022 - Elsevier
Aims Throughout gestation, proteins in the diet are a source of essential amino acids that
are crucial for proper healthy fetal growth and development. The present study was …
are crucial for proper healthy fetal growth and development. The present study was …
Exploring the Mystery of the Tetrahydrobiopterin Synthetic Defect Lethal Mutant leml from Birth to Death in the Silkworm Bombyx mori
D Liang, R Shu, S Jiang, M Xu, Y Cai, H Qin… - International Journal of …, 2022 - mdpi.com
Tetrahydrobiopterin (BH4) is a vital coenzyme for several enzymes involved in diverse
enzymatic reactions in animals, and BH4 deficiency can lead to metabolic and neurological …
enzymatic reactions in animals, and BH4 deficiency can lead to metabolic and neurological …
Drug Response of Iranian Alzheimer's Patients to Rivastigmine Concerning Their Genotype for VDR rs11568820 and MTHFR C677T Variants: A Pharmacogenetic …
ZS Rizi, L Shams, FR Rad, M Zamani - Journal of Molecular Neuroscience, 2024 - Springer
Alzheimer's disease is a neurodegenerative disorder with polygenic etiology. Genetic risk
variants for Alzheimer's disease differ among populations. Thus, discovering them in each …
variants for Alzheimer's disease differ among populations. Thus, discovering them in each …